Bioventix PLC (LSE:BVXP) - Overview

Stock Report

Bioventix PLC BVXP

Last Price
GBX1,300.00

Day Change
0.00|0.00%

As of 09/12/2016
15:00:28 GMT | GBX
Minimum 15 Minutes Delay.

Last Close1,300.00p
Day Range1,250.00 - 1,250.14
Mkt Cap-
52-Wk Range899.50 - 1,600.00
Yield %2.93
ISINGB00B4QVDF07
Volume188
P/E19.13
P/S11.90
P/CF20.27

Share Price

Total Returns 09/12/2016

 Chg (%)  
More ...
Bioventix PLC-4.94 
FTSE 100 TR GBP1.05
 
Financials
201420152016
More ...
Income Statement
Turnover3.544.335.52
Operating Profit2.203.104.21
Net Profit1.822.563.50
Reported EPS35.4249.7967.95
Balance Sheet
Current Assets5.356.428.27
Non Current Assets0.420.490.51
Total Assets5.776.908.78
Current Liabilities0.530.300.55
Total Liabilities0.530.320.57
Total Equity5.246.588.21
Cash Flow
Operating Cash Flow1.772.913.72
Net Change in Cash0.770.781.25
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20174.7074.8010.08--51.00-
20184.5072.70-2.81--61.00-
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
18/11/2016SaleMr. Ian Nicholson1,300.002,00026,000.00
18/11/2016SaleMr. Ian Nicholson1,300.002,00026,000.00
18/11/2016SaleMr. Peter Harrison1,300.002,00026,000.00
18/11/2016SaleMr. Peter Harrison1,300.0098,0001,274,000.00

Company Profile

Bioventix PLC is a biotechnology company. It is engaged in the development of sheep monoclonal antibodies for use in immunodiagnostics engaged in the areas of clinical diagnostics and drugs of abuse testing.
 

Sector

Biotechnology

Market Position

of Companies

Index

FTSE AIM All Share

Outlook

(17/11/2016) no outlook statement

Next Event 21/03/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)0.0013.2516.09
Div Yld (E)0.004.244.23
PEG (E)0.002.760.59
ROCE51.30202.9879.03
Op Mrgn76.22-16.14-13.33
EPS Grwth0.0012.0522.92
Dividends
PreviousLatest
More ...
Record Date28/10/1628/10/16
Ex-Div27/10/1627/10/16
Paid11/11/1611/11/16
Amnt26.0020.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Ian Nicholson
Chief Executive OfficerMr. Peter Harrison
Finance DirectorTreena Turner
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.